{"id":30299,"date":"2024-11-14T15:38:43","date_gmt":"2024-11-14T15:38:43","guid":{"rendered":"https:\/\/kanboapp.com\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/"},"modified":"2024-11-14T15:38:43","modified_gmt":"2024-11-14T15:38:43","slug":"7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards","status":"publish","type":"page","link":"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/","title":{"rendered":"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards"},"content":{"rendered":"<style> @media(min-width:1728px) { .tytulek{font-size:45px!important;margin-right:auto!important;margin-left:auto!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 16px; border-radius: 10px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; } .kolumna-tekst{    flex-basis:850px!important;} .naglowek-duzy {margin-bottom:40px!important; margin-top: 80px!important; font-size:34px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;}  .tekst-para {font-size:19px!important;} .spis { display:block!important; } .paskek-lewy { margin-left:15%!important; margin-right:56px!important; } .paskek-prawy { margin-right:15%!important; margin-left:56px!important; } } @media(min-width: 1440px) and (max-width:1727px) { .tytulek{font-size:45px!important;margin-right:auto!important;margin-left:auto!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 16px; border-radius: 10px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; } .kolumna-tekst{flex-basis:850px!important;} .naglowek-duzy {margin-bottom:40px!important; margin-top: 80px!important; font-size:34px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:19px!important;} .spis { display:block!important; } .paskek-lewy { margin-left:10%!important; margin-right:56px!important; } .paskek-prawy { margin-right:10%!important; margin-left:56px!important; } } @media (min-width: 1024px) and (max-width:1439px) { .tytulek{font-size:45px!important;margin-right:auto!important;margin-left:auto!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;} .artykul{margin-bottom:120px!important; margin-top:120px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 16px; border-radius: 10px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; }  .kolumna-tekst{flex-basis:850px!important;} .naglowek-duzy {margin-bottom:40px!important; margin-top: 80px!important; font-size:34px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:25px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:19px!important;} .spis { display:block!important; } .paskek-lewy { margin-left:5%!important; margin-right:56px!important; } .paskek-prawy { margin-right:5%!important; margin-left:56px!important; } } @media (min-width: 782px) and (max-width:1023px) { .tytulek{font-size:34px!important;margin-right:auto!important;margin-left:auto!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 40px!important; margin-right: 40px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 16px; border-radius: 10px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; }  .kolumna-tekst{flex-basis:100%!important;} .naglowek-duzy {margin-bottom:40px!important; margin-top: 40px!important; font-size:25px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:16px!important;} .spis { display:none!important; } .paskek-lewy { margin-left:2%!important; margin-right:56px!important; } .paskek-prawy { margin-right:2%!important; margin-left:56px!important; } } @media (max-width:781px) {  .tytulek{font-size:34px!important;margin-right:auto!important;margin-left:auto!important;max-width: 1200px!important;} .sekcja-tekst { margin-left: 16px!important; margin-right: 16px!important;}  .artykul{margin-bottom:80px!important; margin-top:30px!important;} .menu-lewe a:hover { background:#E9F4FE!important; font-weight:600!important; font-size:16px!important; cursor:pointer!important; } .menu-lewe a { background:#FAFAFA; padding:10px 16px; border-radius: 10px; display: inline-block; outline: none; color:#0C3658!important; font-weight:600!important; font-size:16px!important; }  .kolumna-tekst{flex-basis:100%!important;} .naglowek-duzy {margin-bottom:40px!important; margin-top: 40px!important; font-size:25px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-maly {margin-bottom:20px!important; font-size:16px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .naglowek-start {margin-bottom:40px!important; margin-top: 0px!important; font-size:19px!important; font-style:normal; font-weight:700!important; letter-spacing:-0.02em!important; line-height:1.2!important;} .tekst-para {font-size:16px!important;} .spis { display:none!important; } } .link a:hover { text-decoration:underline!important; } .banner { margin-top:80px; margin-bottom:80px; } .jazda { position:sticky!important; top: 185px; overflow: auto; max-height: 70vh; }  .fobrazek { margin-bottom: -40px!important; } .sekcja5-przycisk a:hover { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; }  .sekcja5-przycisk a:focus { background: linear-gradient(0deg, rgba(0, 0, 0, 0.15), rgba(0, 0, 0, 0.15)), #ED4B9E!important; } .vlp-layout-blogs .vlp-block-0 {font-weight: 600!important; } .ct-container-narrow {max-width: 1200px!important;}  <\/style><script> function lewemenu(zm) { var elements = document.getElementsByClassName(\"menu-lewe\"); var i,link1,link2; for (i = 0; i < elements.length; i++) {    link1 = elements[i].getElementsByTagName(\"a\");     link1[0].style.fontWeight = \"600\";     link1[0].style.backgroundColor= \"#FAFAFA\"; } link2 = elements[zm].getElementsByTagName(\"a\"); link2[0].style.fontWeight = \"600\"; link2[0].style.backgroundColor= \"#E9F4FE\"; } <\/script><div class=\"wp-block-getwid-section alignfull alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><div class=\"wp-block-columns alignfull artykul is-layout-flex wp-container-core-columns-is-layout-f96e3eba wp-block-columns-is-layout-flex\" style=\"margin-top:0px;margin-bottom:0px\"><div class=\"wp-block-column paskek-lewy spis is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:270px\"><div class=\"wp-block-columns jazda is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\"><p class=\"has-text-align-left has-link-color wp-elements-ce7ce8fee1e672e130d03df3c959d2c6 wp-block-paragraph\" style=\"margin-left:10px;font-size:clamp(16.293px, 1.018rem + ((1vw - 3.2px) * 0.68), 25px);font-style:normal;font-weight:600;letter-spacing:-0.01em;line-height:1.2\">Table of Contents<\/p><p class=\"has-link-color wp-elements-056c6ac2691eae94ab51b533eec36caa wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(0)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section1\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section1\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Introduction<\/a><\/p><\/p><p class=\"has-link-color wp-elements-7f7038d7be3532c64933254b305454a6 wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(1)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section2\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section2\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Embracing Change Without Disruption<\/a><\/p><\/p><p class=\"has-link-color wp-elements-49986caf0e3c97d261a80ac935c01ee9 wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(2)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section3\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section3\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Balancing Complexity with Efficiency<\/a><\/p><\/p><p class=\"has-link-color wp-elements-fa4fbe04ad5f5b0ef4c432bd1ca3b298 wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(3)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section4\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section4\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Fostering Curiosity While Maintaining Control<\/a><\/p><\/p><p class=\"has-link-color wp-elements-1a81a89bf75ebe55d14c51037463470e wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(4)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section5\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section5\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">The Ethics of Innovation: More Than Just Profit<\/a><\/p><\/p><p class=\"has-link-color wp-elements-53520b2f321eba3d5b17fcf467acaa6e wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(5)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section6\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section6\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Innovation as the Path to Better Living \u2013 Balancing Convenience with Sustainability<\/a><\/p><\/p><p class=\"has-link-color wp-elements-23fd543edca90b5335300b2a5f1276eb wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(6)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section7\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section7\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Innovation vs. Tradition: Navigating Industry Expectations<\/a><\/p><\/p><p class=\"has-link-color wp-elements-e7cd301fb80e8335dcff66039fa61ccb wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(7)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section8\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section8\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Transforming Innovation from a Task to a Culture<\/a><\/p><\/p><p class=\"has-link-color wp-elements-c75909f2d0f2389b48147750980695fb wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(8)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section9\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section9\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">KanBo Cookbook: Utilizing KanBo for Innovation Management <\/a><\/p><\/p><p class=\"has-link-color wp-elements-0a33d26b9cd85ab23db317bdd2b28092 wp-block-paragraph\"><p class=\"menu-lewe has-link-color\" onclick=\"lewemenu(9)\"><a href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section10\" data-type=\"URL\" data-id=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#section10\"  style=\"font-size:clamp(14px, 0.875rem + ((1vw - 3.2px) * 0.391), 19px);font-style:normal;font-weight:600;line-height:1.2;color:#0c3658\">Glossary and terms<\/a><\/p><\/p><\/div><\/div><\/div><div class=\"wp-block-column kolumna-tekst is-layout-flow wp-block-column-is-layout-flow\"><div class=\"wp-block-getwid-section alignfull sekcja-tekst alignfull getwid-margin-top-none getwid-margin-bottom-none getwid-section-content-full-width\"><div class=\"wp-block-getwid-section__wrapper getwid-padding-top-none getwid-padding-bottom-none getwid-padding-left-none getwid-padding-right-none getwid-margin-left-none getwid-margin-right-none\" style=\"min-height:100vh\"><div class=\"wp-block-getwid-section__inner-wrapper\"><div class=\"wp-block-getwid-section__background-holder\"><div class=\"wp-block-getwid-section__background has-background\" style=\"background-color:#fafafa\"><\/div><div class=\"wp-block-getwid-section__foreground\"><\/div><\/div><div class=\"wp-block-getwid-section__content\"><div class=\"wp-block-getwid-section__inner-content\"><h1 class=\"wp-block-heading tytulek\" style=\"margin-bottom:40px;font-size:clamp(21.536px, 1.346rem + ((1vw - 3.2px) * 1.052), 35px);font-style:normal;font-weight:700;letter-spacing:-0.02em;line-height:1.2\">7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards<\/h1><h2 class=\"wp-block-heading naglowek-duzy\" id=\"section1\">Introduction<\/h2><p class=\"tekst-para wp-block-paragraph\">In the ever-evolving landscape of pharmaceuticals, the question isn't merely whether to innovate but how swiftly and effectively we can implement innovation in an industry inherently resistant to change. This paradox is at the heart of the development of essential drugs like Praluent, where the push for groundbreaking advancements is met with regulatory, logistical, and cultural barriers. Innovation is not just a catalyst for creating life-saving medications; it acts as a bridge, propelling us past outdated methodologies towards more efficient, impactful solutions.<\/p><p class=\"tekst-para wp-block-paragraph\">For Praluent, a cholesterol-lowering medication, innovation could mean enhancing formulation processes, optimizing delivery mechanisms, or even pioneering patient adherence strategies. Such innovation ensures that the drug remains on the cutting edge, maximizes its therapeutic potential, and reaches those in need more effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">Enter KanBo, a dynamic platform offering robust tools to nurture and manage innovation tailored to the unique needs of any pharmaceutical organization. KanBo\u2019s Spaces feature, in particular, provides a collaborative and organized environment specifically designed for managing innovation initiatives. This allows teams to do more than just share and track ideas; it enables them to manage an entire workflow aligned with strategic goals within a structured space. By leveraging Spaces, teams can harness collective creativity and systematically transform innovative concepts into tangible improvements for Praluent, thus bridging the gap between strategic innovation and operational execution.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section2\">Embracing Change Without Disruption<\/h3><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, there is a paradox between a keen desire for pioneering solutions and the innate resistance to change. What causes this reluctance, especially in organizations keen on advancing healthcare? When contemplating innovations like Praluent, a medication aimed at particular health challenges, why might there be hesitation to further innovate or implement changes within the system? The answer often lies in the delicate balance between innovation and the potential disruptions it may cause to established processes.<\/p><p class=\"tekst-para wp-block-paragraph\">Structured innovation is a remedy to this hesitation, providing a pathway to change without overwhelming disruption. By adopting a systematic approach, such as the one facilitated by KanBo's Card Status feature, organizations can manage their innovation projects more effectively. The Card Status feature in KanBo allows teams to track the stages of innovation projects with clear indicators such as \"To Do,\" \"In Progress,\" \"Completed,\" or \"On Hold.\" This visibility into the progress of various initiatives ensures that teams can navigate changes strategically, with an understanding of where efforts are concentrated and what remains to be tackled.<\/p><p class=\"tekst-para wp-block-paragraph\">Why does structured innovation prove invaluable in pharmaceutical settings? It minimizes the chaos that often accompanies shifts in strategy or the introduction of new processes. By providing teams with a clear view of what\u2019s in progress, what\u2019s already accomplished, and what requires a pause, structured approaches enhance adaptability. This framework not only supports the innovative drive but also maintains alignment with the broader strategic goals of the organization.<\/p><p class=\"tekst-para wp-block-paragraph\">Ultimately, the key to fostering a culture that embraces change in pharmaceuticals lies in adopting tools and processes that mitigate disruption. KanBo stands out as an example of how structured progress tracking can facilitate innovation without the fear of instability, ensuring that advancements like those possible with Praluent can be pursued with confidence and clarity. Isn\u2019t it time for the industry to fully embrace such methodologies to achieve its groundbreaking goals?<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section3\">Balancing Complexity with Efficiency<\/h3><p class=\"tekst-para wp-block-paragraph\">In pharmaceutical companies, innovations often aim to streamline processes and improve efficiencies. However, these advancements can sometimes introduce complexities that overshadow their benefits. Take, for example, a drug like Praluent. Developed to treat specific health conditions efficiently, its introduction may add complexity in terms of distribution, administration, and monitoring.<\/p><p class=\"tekst-para wp-block-paragraph\">To combat this, pharmaceutical companies can employ efficient systems that help manage and simplify these complexities. A tool such as KanBo's Space template can be particularly useful. By automating repetitive tasks and providing a structured, reusable framework for project management, teams can reduce administrative burdens and focus on higher-value work such as research and patient care.<\/p><p class=\"tekst-para wp-block-paragraph\">The Space template includes preconfigured elements like cards, groupings, and statuses, which set a strong foundation for any pharmaceutical team's workflow. For a team managing a drug like Praluent, this means they can quickly set up and standardize their operations, allowing them to allocate more resources towards innovation and patient outcomes rather than being bogged down by operational details.<\/p><p class=\"tekst-para wp-block-paragraph\">Reflecting on these solutions, it's important to ask whether they truly simplify tasks or simply shift where complexity lies. While KanBo's Space template seems to manage complexity by organizing tasks and streamlining processes, teams must continually evaluate their systems. After all, genuine simplification comes from constantly re-assessing processes, ensuring that each innovation truly minimizes complexity rather than redistributing it.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section4\">Fostering Curiosity While Maintaining Control<\/h3><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, there exists a delicate tension between fostering a culture of curiosity and the imperative for control. On one hand, the pursuit of scientific advancement hinges heavily on the ability to explore new ideas, challenge existing paradigms, and innovate without the constraints of rigid structures. On the other hand, the industry must adhere to stringent regulatory standards, ensure patient safety, and maintain meticulous operational processes, all of which necessitate a degree of control.<\/p><p class=\"tekst-para wp-block-paragraph\">Innovation within pharmaceuticals, especially with pioneering drugs like Praluent, requires a strategic balance between these forces. To advance treatment options and develop cutting-edge therapies, companies must cultivate an environment where curiosity and exploration are encouraged at every level. This means supporting scientists and researchers in their quest to uncover new mechanisms of action, test novel compounds, and experiment with potential breakthroughs.<\/p><p class=\"tekst-para wp-block-paragraph\">However, this exploration must be guided by structured processes to ensure that it aligns with regulatory compliance, ethical standards, and business strategies. Here is where tools like KanBo become invaluable. By leveraging the Card user feature, pharmaceutical companies can manage user roles and permissions effectively, striking a balance between encouraging innovative exploration and maintaining controlled, reliable processes. This feature allows leadership to assign specific roles, such as Person Responsible and Co-Workers, to manage who has access to sensitive information and who is involved in various stages of a project.<\/p><p class=\"tekst-para wp-block-paragraph\">In promoting innovation, it is crucial that individuals at all levels are empowered to contribute ideas and participate in problem-solving initiatives. The KanBo Card user feature ensures that team members remain informed about every action related to a card, fostering transparency and communication while allowing leadership to maintain oversight and ensure compliance with protocols.<\/p><p class=\"tekst-para wp-block-paragraph\">As pharmaceutical companies strive to harness both curiosity and control, tools that provide structured flexibility are essential. Praluent represents a culmination of this balance, embodying the spirit of persistent curiosity while conforming to rigorous industry standards. By embracing technologies that facilitate seamless collaboration and controlled dissemination of information, the industry can better meet the dual demands of innovative exploration and operational control, ultimately leading to advances that redefine patient care.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section5\">The Ethics of Innovation: More Than Just Profit<\/h3><p class=\"tekst-para wp-block-paragraph\">In the realm of pharmaceutical innovation, ethical considerations play a pivotal role in guiding decisions that have far-reaching impacts on society, ecology, and future generations. The question \"Just because we can innovate, should we?\" is particularly pertinent. This consideration calls for a deep reflection on the moral implications of developing new drugs and treatments, including the potential consequences on public health, the environment, and socio-economic structures.<\/p><p class=\"tekst-para wp-block-paragraph\">One such pharmaceutical innovation is Praluent, a medication that lowers cholesterol levels, aiding in the prevention of cardiovascular conditions. While its medical benefits are significant, it is essential to approach its development and distribution with a conscientious framework. Here's how Praluent can navigate the ethical landscape and make responsible choices to ensure its long-term impact aligns with societal values:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Evaluating Long-term Impacts: A comprehensive evaluation of how Praluent influences not just immediate health outcomes, but also potential environmental and societal effects, should be prioritized. This includes considering the ecological footprint of its production and distribution and its accessibility to various demographics.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Ensuring Equitable Access: Ethical innovation demands that advancements do not exacerbate existing health disparities. Efforts should be focused on making Praluent affordable and accessible to underprivileged populations, thereby promoting health equity.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Transparent Communication: Stakeholders, including patients, healthcare professionals, and regulators, should be informed transparently about the benefits and potential risks associated with Praluent. Transparent communication builds trust and empowers informed decision-making.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Collaboration and Responsibility: Using tools like KanBo's Workspace, the assignment of a Responsible Person, and involvement of Co-Workers can facilitate collaborative ethical decision-making processes. The Responsible Person can oversee the development process, ensuring that ethical guidelines are adhered to at all stages. Meanwhile, Co-Workers can contribute diverse perspectives and expertise, enriching the decision-making process.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Monitoring and Feedback Mechanisms: Continuous monitoring and the establishment of feedback channels can help track the real-world impacts of Praluent post-launch. This insight can guide adjustments and improvements, ensuring that any emerging ethical concerns are swiftly addressed.<\/p><p class=\"tekst-para wp-block-paragraph\">By embedding these ethical considerations into the innovation process, Praluent can set a precedent in responsible pharmaceutical development. Ultimately, the goal is to ensure that innovation serves humanity positively, fostering advancements that are sustainable, equitable, and mindful of their broader implications. The use of collaborative tools like KanBo can further support these endeavors, promoting thorough and considered strategic decisions.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section6\">Innovation as the Path to Better Living \u2013 Balancing Convenience with Sustainability<\/h3><p class=\"tekst-para wp-block-paragraph\">In recent years, the pharmaceutical industry has seen a growing demand for more convenient solutions, largely driven by advancements in technology and a shift towards patient-centered care. While these solutions offer numerous benefits, such as improving patient adherence and streamlining healthcare processes, they often come with hidden costs, notably their environmental impact.<\/p><p class=\"tekst-para wp-block-paragraph\">Pharmaceutical companies are under increasing pressure to deliver medications that are not only effective but also easy to use and access. However, the push for convenience, like quick-to-administer drugs or single-use medical devices, often prioritizes short-term ease over long-term sustainability. This can lead to significant environmental repercussions, such as increased medical waste, higher energy consumption in production, and challenges in proper disposal of pharmaceutical products. <\/p><p class=\"tekst-para wp-block-paragraph\">A prime example of addressing these hidden costs while still offering innovative solutions is Praluent. By focusing on sustainable innovation practices, Praluent can set a benchmark for the industry. Here\u2019s how they can steer towards eco-friendly practices:<\/p><p class=\"tekst-para wp-block-paragraph\">1. Sustainable Manufacturing: Implementing green chemistry principles in the production process can help reduce the carbon footprint and minimize waste. This might include using biodegradable materials or optimizing processes to lower energy consumption.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Eco-friendly Packaging: The development of novel packaging solutions that are both recyclable and made from sustainable materials can significantly decrease the environmental impact.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Lifecycle Analysis: Conducting comprehensive lifecycle analyses helps identify stages in the product lifecycle that are resource-intensive or environmentally damaging, thus enabling more targeted improvements.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Collaborative Platforms: Utilizing platforms like KanBo's Document group can facilitate collaboration across teams, encouraging them to centralize insights related to sustainable practices. By sharing documentation, research findings, and eco-friendly innovation strategies, teams can work cohesively towards greener solutions.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Patient and Provider Education: Encouraging responsible use and disposal of pharmaceutical products can help mitigate environmental impacts. Providing clear guidelines and educational materials supports this initiative.<\/p><p class=\"tekst-para wp-block-paragraph\">By pursuing these sustainable innovation practices, Praluent can help lead the charge not just towards short-term convenience, but towards a more balanced approach that prioritizes both patient needs and environmental stewardship. As the industry continues to advance, integrating such sustainable strategies will be crucial for aligning with global efforts to protect and preserve ecological health.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section7\">Innovation vs. Tradition: Navigating Industry Expectations<\/h3><p class=\"tekst-para wp-block-paragraph\">In the pharmaceutical industry, the intersection of traditional expectations and innovative practices is a landscape fraught with both profound challenges and opportunities. This dichotomy is particularly significant as companies navigate the landscape of modern drug development and marketing. One compelling example of this tension is evident in the approach to the cholesterol-lowering drug, Praluent. <\/p><p class=\"tekst-para wp-block-paragraph\">Traditional expectations in the pharmaceutical industry often emphasize rigorous adherence to time-tested research and development protocols, comprehensive clinical trials, regulatory compliance, and extensive market analysis. These methods are seen as pillars of credibility and safety that reassure both regulators and consumers. However, these conventional approaches can sometimes stifle innovation, limiting the speed at which new therapies are brought to market.<\/p><p class=\"tekst-para wp-block-paragraph\">On the other hand, innovative practices in pharmaceuticals challenge these traditional norms by advocating for agility, flexibility, and speed in the development pipeline. This includes leveraging cutting-edge technologies such as artificial intelligence for drug discovery, prioritizing precision medicine, and adopting accelerated approval pathways. While these innovations promise swift advancements and personalized patient care, they can clash with established norms that prioritize thoroughness over speed.<\/p><p class=\"tekst-para wp-block-paragraph\">Balancing respect for established methods with the need for modern solutions requires a nuanced approach. It involves acknowledging the value of traditional practices in ensuring safety and reliability while also embracing innovation that can enhance the efficacy and efficiency of treatments. <\/p><p class=\"tekst-para wp-block-paragraph\">Praluent, as a pioneering cholesterol-lowering therapy, exemplifies how companies can navigate this tension. This drug, which targets specific proteins to effectively lower cholesterol, represents a shift from standard treatment regimes. However, by adhering to established rigorous clinical trial protocols, Praluent earned credibility and adoption in the market while showcasing the benefits of innovative drug mechanisms.<\/p><p class=\"tekst-para wp-block-paragraph\">To effectively bridge the gap between traditional and innovative practices, utilizing tools like KanBo Card templates can be immensely beneficial. These templates serve as a structured foundation for integrating best practices in both traditional and innovative approaches. They provide a uniform starting point for developing strategies that respect established protocols while fostering innovation. By streamlining processes and ensuring consistency in evaluation and implementation, these templates enable teams to maintain a balance between necessary rigor and the flexibility required for innovation.<\/p><p class=\"tekst-para wp-block-paragraph\">In conclusion, the pharmaceutical industry must continue to find ways to balance respect for its rich legacy of traditional practices with the dynamic demands of innovation. Praluent is a prime example of how this balance can be navigated successfully, ensuring not just regulatory compliance and consumer trust, but also timely and effective treatment delivery. The strategic use of tools such as KanBo Card templates can play a crucial role in aligning the different facets of this complex landscape, ultimately leading to better outcomes in healthcare delivery.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section8\">Transforming Innovation from a Task to a Culture<\/h3><p class=\"tekst-para wp-block-paragraph\">Innovation in the pharmaceutical industry is crucial not only for staying competitive but also for advancing patient care and addressing unmet medical needs. However, innovation is not a one-time project or a cursory objective to be checked off a list; it is a cultural shift that requires a sustained, pervasive approach. To truly integrate continuous innovation into their core culture, pharmaceutical companies like Praluent must adopt strategies that support this transformation.<\/p><p class=\"tekst-para wp-block-paragraph\"> Cultural Shifts for Continuous Innovation<\/p><p class=\"tekst-para wp-block-paragraph\">1. Promote a Culture of Experimentation:<\/p><p class=\"tekst-para wp-block-paragraph\">   Encourage team members to experiment with new ideas without fear of failure. Innovation thrives in an environment where employees are empowered to take risks and explore novel solutions to complex problems.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Leverage Cross-Disciplinary Collaboration:<\/p><p class=\"tekst-para wp-block-paragraph\">   Foster collaboration across different departments. When teams with diverse expertise work together, they can view challenges from multiple angles, leading to creative and comprehensive solutions.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Encourage Continuous Learning:<\/p><p class=\"tekst-para wp-block-paragraph\">   Invest in ongoing training and development opportunities. Staying updated with the latest advancements in technology and pharmaceuticals helps employees remain agile and innovate effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Emphasize Long-Term Vision:<\/p><p class=\"tekst-para wp-block-paragraph\">   While short-term wins are important, maintaining a focus on long-term goals ensures that innovation efforts are aligned with the company\u2019s future aspirations. <\/p><p class=\"tekst-para wp-block-paragraph\"> Integrating Continuous Innovation with KanBo<\/p><p class=\"tekst-para wp-block-paragraph\">To foster this innovative culture, utilizing tools like KanBo's Timeline and Gantt Charts can be transformative. Here's how:<\/p><p class=\"tekst-para wp-block-paragraph\">- KanBo Timeline for Tracking Progress:<\/p><p class=\"tekst-para wp-block-paragraph\">  The Timeline feature in KanBo offers a visual representation of ongoing innovation projects. By mapping out project dates on a horizontal time axis, teams can better grasp project life cycles and ensure that milestones are met. This flexibility allows teams to adjust due dates dynamically, ensuring that projects remain on track.<\/p><p class=\"tekst-para wp-block-paragraph\">- Gantt Charts for Complex, Long-Term Planning:<\/p><p class=\"tekst-para wp-block-paragraph\">  For extensive and intricate projects like drug development that require meticulous planning over several years, KanBo's Gantt Chart view becomes indispensable. It enables teams to visualize all time-dependent tasks, offering a chronological bar-chart representation that is ideal for planning each phase of a project meticulously.<\/p><p class=\"tekst-para wp-block-paragraph\">- Facilitating Transparency and Accountability:<\/p><p class=\"tekst-para wp-block-paragraph\">  These tools help create an open environment where everyone involved in a project understands their roles, responsibilities, and timelines. This transparency fosters accountability and ensures that teams remain aligned with the innovation objectives.<\/p><p class=\"tekst-para wp-block-paragraph\"> Why Continuous Innovation is Crucial<\/p><p class=\"tekst-para wp-block-paragraph\">1. Response to Rapid Technological Advances:<\/p><p class=\"tekst-para wp-block-paragraph\">   The pharmaceutical industry evolves quickly with new technologies like AI and genomics. A culture of continuous innovation enables a quicker, more effective response to these changes.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Meeting Diverse and Changing Patient Needs:<\/p><p class=\"tekst-para wp-block-paragraph\">   As patient demographics and healthcare needs change, staying innovative ensures that new drugs and therapies can address these evolving demands effectively.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Enhancing Competitive Edge:<\/p><p class=\"tekst-para wp-block-paragraph\">   With increasing competition, innovation is key to differentiating products and maintaining a competitive advantage in the market.<\/p><p class=\"tekst-para wp-block-paragraph\">Embracing continuous innovation through a cultural shift is not only beneficial but necessary for a pharmaceutical company seeking to thrive in today's dynamic environment. Tools like KanBo\u2019s Timeline and Gantt Charts support this transition by providing teams with the means to manage, track, and plan innovation projects holistically. By making innovation part of its core culture, Praluent can ensure sustained success and continue to make significant contributions to the healthcare sector.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section9\">KanBo Cookbook: Utilizing KanBo for Innovation Management <\/h3><p class=\"tekst-para wp-block-paragraph\"> Cookbook to Implement KanBo for Praluent Innovation Management<\/p><p class=\"tekst-para wp-block-paragraph\"> Objective<\/p><p class=\"tekst-para wp-block-paragraph\">Leverage KanBo's features and principles to strategically enhance innovation management within Praluent in the Pharmaceutical sector. The aim is to create a structured and collaborative environment to foster idea development, manage innovation projects efficiently, and align them with strategic organizational goals.<\/p><p class=\"tekst-para wp-block-paragraph\"> KanBo Features in Use<\/p><p class=\"tekst-para wp-block-paragraph\">1. Workspaces & Spaces: Organizing teams and projects.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Folders: Categorizing and managing specific projects.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Cards: Managing actionable tasks or ideas with detailed information.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Card and Space Templates: Standardizing processes and efficiency.<\/p><p class=\"tekst-para wp-block-paragraph\">5. Document Groups: Integrating and organizing essential documents for project tasks.<\/p><p class=\"tekst-para wp-block-paragraph\">6. Timeline & Gantt Chart View: Planning and visualization of project timelines.<\/p><p class=\"tekst-para wp-block-paragraph\">7. Comments, and Discussion Tools: Facilitating communication.<\/p><p class=\"tekst-para wp-block-paragraph\">8. External Collaboration: Involving stakeholders outside the organization securely.<\/p><p class=\"tekst-para wp-block-paragraph\">9. Roles and Permissions Management: Defining user access and responsibilities.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step-by-Step Solution<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 1: Create a Workspace for Praluent Innovation<\/p><p class=\"tekst-para wp-block-paragraph\">1. Navigate to KanBo's main dashboard and select 'Create New Workspace'.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Name the workspace \"Praluent Innovation Hub\".<\/p><p class=\"tekst-para wp-block-paragraph\">3. Define the workspace as 'Org-wide' to encourage cross-departmental collaboration.<\/p><p class=\"tekst-para wp-block-paragraph\">4. Set permissions to allow designated innovation leads as 'Owners', project managers as 'Members', and external collaborators as 'Visitors'.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 2: Develop a Folder Structure<\/p><p class=\"tekst-para wp-block-paragraph\">1. Within \"Praluent Innovation Hub\", go to Workspaces & Spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Create folders labeled \"New Product Development\", \"Regulatory Innovations\", \"Process Improvements\", and \"Technology Integrations\".<\/p><p class=\"tekst-para wp-block-paragraph\">3. Ensure each folder has unique access permissions to maintain confidentiality where required.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 3: Establish Spaces<\/p><p class=\"tekst-para wp-block-paragraph\">1. For each folder, create a corresponding Space with Workflow: e.g. \"Praluent New Formulations\" under \"New Product Development\".<\/p><p class=\"tekst-para wp-block-paragraph\">2. Use Space Templates to ensure consistent setup with predefined cards, statuses, and group listings.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 4: Implement Card System for Tasks<\/p><p class=\"tekst-para wp-block-paragraph\">1. Within a Space, click the plus icon to add Cards for specific tasks or ideas, e.g. \"Research New Active Ingredients\".<\/p><p class=\"tekst-para wp-block-paragraph\">2. Customize the card with essential details\u2014description, due dates, and documents.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Assign a Responsible Person and include Co-Workers as needed.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 5: Facilitate User Collaboration<\/p><p class=\"tekst-para wp-block-paragraph\">1. Invite users: For each Space, invite internal stakeholders and select external collaborators (using the External Collaboration feature).<\/p><p class=\"tekst-para wp-block-paragraph\">2. Conduct a kickoff meeting to train team members in using the KanBo interface efficiently.<\/p><p class=\"tekst-para wp-block-paragraph\">3. Leverage comments and @mentions for task discussion.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 6: Organize Document Groups<\/p><p class=\"tekst-para wp-block-paragraph\">1. On each Card, integrate relevant project documents and organize them into Document Groups for easy access and management.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 7: Implement Planning and Visualization Tools<\/p><p class=\"tekst-para wp-block-paragraph\">1. Use the Timeline feature to visualize card-related milestones.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Utilize the Gantt Chart View for longer-term planning and dependencies that affect the innovation timeline.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 8: Review and Refine Process<\/p><p class=\"tekst-para wp-block-paragraph\">1. Regularly monitor project progress using the Activity Stream.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Adjust workflows based on data-driven insights to enhance productivity.<\/p><p class=\"tekst-para wp-block-paragraph\"> Step 9: Evaluate and Optimize Innovation Management<\/p><p class=\"tekst-para wp-block-paragraph\">1. Use KanBo's Forecast Chart to assess project viability and potential challenges.<\/p><p class=\"tekst-para wp-block-paragraph\">2. Gather team feedback to refine the process further and improve future iterations.<\/p><p class=\"tekst-para wp-block-paragraph\">By methodically implementing these steps, Praluent can leverage KanBo's advanced features to foster a culture of innovation, streamline project management efforts, and align their initiatives seamlessly with organizational goals.<\/p><h3 class=\"wp-block-heading naglowek-duzy\" id=\"section10\">Glossary and terms<\/h3><p class=\"tekst-para wp-block-paragraph\"> KanBo Glossary<\/p><p class=\"tekst-para wp-block-paragraph\"> Introduction<\/p><p class=\"tekst-para wp-block-paragraph\">KanBo is a versatile work coordination platform designed to bridge the gap between strategic company objectives and daily operations. With robust integration capabilities with Microsoft products such as SharePoint, Teams, and Office 365, KanBo facilitates real-time visualization and efficient management of workflows. Its unique hierarchical model and hybrid environment offer a distinct advantage over traditional SaaS applications, making it suitable for organizations requiring flexibility, compliance, and detailed customization. Below is a glossary to help you understand key terms and concepts within the KanBo environment.<\/p><p class=\"tekst-para wp-block-paragraph\"> Key Terms<\/p><p class=\"tekst-para wp-block-paragraph\">- Workspace: <\/p><p class=\"tekst-para wp-block-paragraph\">  - A collection of related Spaces, categorized by project, team, or topic. Workspaces facilitate easier navigation and collaboration by consolidating pertinent Spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">  <\/p><p class=\"tekst-para wp-block-paragraph\">- Spaces:<\/p><p class=\"tekst-para wp-block-paragraph\">  - A component within Workspaces, reflecting projects or focus areas. Spaces allow for task management and collaboration by housing actionable items called Cards.<\/p><p class=\"tekst-para wp-block-paragraph\">- Folders:<\/p><p class=\"tekst-para wp-block-paragraph\">  - Organize Spaces into specific categories within a Workspace. They help structure projects and streamline access to various Spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">- Cards:<\/p><p class=\"tekst-para wp-block-paragraph\">  - The fundamental units of tasks or actionable items within a Space. Cards contain information such as notes, files, comments, and to-do lists, essential for task management.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Status:<\/p><p class=\"tekst-para wp-block-paragraph\">  - Indicators that reflect a Card's stage or condition (e.g., To Do, In Progress, Completed), crucial for tracking project progress and conducting analysis.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card User:<\/p><p class=\"tekst-para wp-block-paragraph\">  - Individuals assigned to a Card, including the Person Responsible (oversees task completion) and Co-Workers (assist in task performance).<\/p><p class=\"tekst-para wp-block-paragraph\">- Responsible Person:<\/p><p class=\"tekst-para wp-block-paragraph\">  - The user responsible for overseeing Card realization. The role is singular per Card but can be reassigned anytime.<\/p><p class=\"tekst-para wp-block-paragraph\">- Co-Worker:<\/p><p class=\"tekst-para wp-block-paragraph\">  - A participant in task execution on a Card, supporting the Responsible Person.<\/p><p class=\"tekst-para wp-block-paragraph\">- Space Template:<\/p><p class=\"tekst-para wp-block-paragraph\">  - A reusable and preconfigured Space structure that includes predefined Cards, statuses, and groupings. Space templates save time and ensure consistency across new Spaces.<\/p><p class=\"tekst-para wp-block-paragraph\">- Card Template:<\/p><p class=\"tekst-para wp-block-paragraph\">  - A predefined layout for creating Cards, providing default elements and details that standardize new card creation.<\/p><p class=\"tekst-para wp-block-paragraph\">- Document Group:<\/p><p class=\"tekst-para wp-block-paragraph\">  - A feature that arranges Card documents based on any condition, such as type or purpose. It keeps documents organized without affecting external storage sources.<\/p><p class=\"tekst-para wp-block-paragraph\">- Timeline:<\/p><p class=\"tekst-para wp-block-paragraph\">  - A Kanban view feature visually representing Card dates on a horizontal axis for scheduling and deadline management.<\/p><p class=\"tekst-para wp-block-paragraph\">- Gantt Chart View:<\/p><p class=\"tekst-para wp-block-paragraph\">  - A visualization option for time-dependent Cards, displaying them chronologically in a bar chart format. Ideal for complex, long-term project planning.<\/p><p class=\"tekst-para wp-block-paragraph\">Leveraging these concepts allows users to fully maximize KanBo\u2019s capabilities for effective workflow management and strategic implementation.<\/p><div style=\"height:120px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"wp-block-column paskek-prawy spis is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:270px\"><div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-995f960e wp-block-columns-is-layout-flex\"><div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-left:16px\"><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":10472,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-30299","page","type-page","status-publish","hentry"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\r\n<title>7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards - KanBo<\/title>\r\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\r\n<link rel=\"canonical\" href=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/\" \/>\r\n<meta property=\"og:locale\" content=\"en_US\" \/>\r\n<meta property=\"og:type\" content=\"article\" \/>\r\n<meta property=\"og:title\" content=\"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards - KanBo\" \/>\r\n<meta property=\"og:url\" content=\"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/\" \/>\r\n<meta property=\"og:site_name\" content=\"KanBo\" \/>\r\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\r\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"19 minutes\" \/>\r\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/knowledgehub\\\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/knowledgehub\\\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\\\/\",\"name\":\"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards - KanBo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\"},\"datePublished\":\"2024-11-14T15:38:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/knowledgehub\\\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kanboapp.com\\\/en\\\/knowledgehub\\\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/knowledgehub\\\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"KnowledgeHub\",\"item\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/knowledgehub\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"name\":\"KanBo\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#organization\",\"name\":\"KanBo\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"contentUrl\":\"https:\\\/\\\/kanboapp.com\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/image-122.png\",\"width\":196,\"height\":52,\"caption\":\"KanBo\"},\"image\":{\"@id\":\"https:\\\/\\\/kanboapp.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\r\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards - KanBo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/","og_locale":"en_US","og_type":"article","og_title":"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards - KanBo","og_url":"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/","og_site_name":"KanBo","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"19 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/","url":"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/","name":"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards - KanBo","isPartOf":{"@id":"https:\/\/kanboapp.com\/en\/#website"},"datePublished":"2024-11-14T15:38:43+00:00","breadcrumb":{"@id":"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kanboapp.com\/en\/knowledgehub\/7-ways-praluent-innovation-challenges-and-advances-pharmaceutical-industry-standards\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kanboapp.com\/en\/"},{"@type":"ListItem","position":2,"name":"KnowledgeHub","item":"https:\/\/kanboapp.com\/en\/knowledgehub\/"},{"@type":"ListItem","position":3,"name":"7 Ways Praluent Innovation Challenges and Advances Pharmaceutical Industry Standards"}]},{"@type":"WebSite","@id":"https:\/\/kanboapp.com\/en\/#website","url":"https:\/\/kanboapp.com\/en\/","name":"KanBo","description":"","publisher":{"@id":"https:\/\/kanboapp.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kanboapp.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kanboapp.com\/en\/#organization","name":"KanBo","url":"https:\/\/kanboapp.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","contentUrl":"https:\/\/kanboapp.com\/wp-content\/uploads\/2023\/04\/image-122.png","width":196,"height":52,"caption":"KanBo"},"image":{"@id":"https:\/\/kanboapp.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/30299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/comments?post=30299"}],"version-history":[{"count":0,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/30299\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/pages\/10472"}],"wp:attachment":[{"href":"https:\/\/kanboapp.com\/en\/wp-json\/wp\/v2\/media?parent=30299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}